HCWB Stock Analysis: Buy, Sell, or Hold?
HCWB - HCW Biologics Inc. Common Stock
$1.63
0.00 (0.00%)
β²
5d:
-17.68%
30d:
+365.05%
90d:
+162.86%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When HCWB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called HCWB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: HCWB is down 17.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: HCWB is down 17.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HCWB is currently trading at $1.63, which is considered slightly high relative to its 30-day fair value range of $0.27 to $2.03.
Technical Outlook: Technically, HCWB is in a downtrend. Immediate support is located at $1.03, while resistance sits at $3.99.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+206.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HCWB is in a downtrend. Immediate support is located at $1.03, while resistance sits at $3.99.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+206.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.27 -
$2.03
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 206.7% below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -17.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.27 -
$2.03
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.03
Resistance Level
$3.99
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.70
Wall Street Target
$5.00
(+206.7%)
Revenue Growth (YoY)
129080.7%
Profit Margin
-34.7%
Share & Embed Analysis
Last updated: June 06, 2026 5:26 AM ET
Data refreshes hourly during market hours. Next update: 6:26 AM
Data refreshes hourly during market hours. Next update: 6:26 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCWB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend BiotechΒ Corp |
STRONG BUY
22 analysts |
$55 | 64 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$252 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
|
APLS
Apellis Pharmaceuticals β¦ |
BUY
22 analysts |
$41 | 59 HOLD |